ArticleScientific reports2023

Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variants.

Scott A Hollingsworth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.